These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 22102453)
101. Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles. Serra A; Ruff R; Kaminski H; Leigh RJ Ann N Y Acad Sci; 2011 Sep; 1233():26-33. PubMed ID: 21950972 [TBL] [Abstract][Full Text] [Related]
102. Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors. Oda K; Lambert EH; Lennon VA; Palmer AC Muscle Nerve; 1984; 7(9):705-16. PubMed ID: 6543919 [TBL] [Abstract][Full Text] [Related]
103. How myasthenia gravis alters the safety factor for neuromuscular transmission. Ruff RL; Lennon VA J Neuroimmunol; 2008 Sep; 201-202():13-20. PubMed ID: 18632162 [TBL] [Abstract][Full Text] [Related]
104. Endplate contributions to the safety factor for neuromuscular transmission. Ruff RL Muscle Nerve; 2011 Dec; 44(6):854-61. PubMed ID: 22102453 [TBL] [Abstract][Full Text] [Related]
105. Electrophysiology of postsynaptic activation. Ruff RL Ann N Y Acad Sci; 1998 May; 841():57-70. PubMed ID: 9668221 [TBL] [Abstract][Full Text] [Related]
106. Electrical exploration of acetylcholine receptors. Katz B Postgrad Med J; 1981; 57 Suppl 1():84-8. PubMed ID: 6272255 [TBL] [Abstract][Full Text] [Related]
107. Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles. Serra A; Ruff RL; Leigh RJ Ann N Y Acad Sci; 2012 Dec; 1275(1):129-35. PubMed ID: 23278588 [TBL] [Abstract][Full Text] [Related]
108. Neuromuscular synapse electrophysiology in myasthenia gravis animal models. Plomp JJ; Huijbers MGM; Verschuuren JJGM Ann N Y Acad Sci; 2018 Jan; 1412(1):146-153. PubMed ID: 29068559 [TBL] [Abstract][Full Text] [Related]
110. [Major mechanisms involved in the synaptic transmission of the neuromuscular apparatus]. Rigoard S; Wager M; Buffenoir K; Bauche S; Giot JP; Maixent JM; Rigoard P Neurochirurgie; 2009 Mar; 55 Suppl 1():S22-33. PubMed ID: 19230941 [TBL] [Abstract][Full Text] [Related]
111. Neurophysiology of the neuromuscular junction: overview. Ruff RL Ann N Y Acad Sci; 2003 Sep; 998():1-10. PubMed ID: 14592857 [TBL] [Abstract][Full Text] [Related]
112. Molecular regulation of postsynaptic differentiation at the neuromuscular junction. Madhavan R; Peng HB IUBMB Life; 2005 Nov; 57(11):719-30. PubMed ID: 16511964 [TBL] [Abstract][Full Text] [Related]
113. [Genetic defects and disorders at the neuromuscular junction]. Ohno K Brain Nerve; 2011 Jul; 63(7):669-78. PubMed ID: 21747136 [TBL] [Abstract][Full Text] [Related]
114. Drug-induced modification of ionic conductance at the neuromuscular junction. Lambert JJ; Durant NN; Henderson EG Annu Rev Pharmacol Toxicol; 1983; 23():505-39. PubMed ID: 6307128 [No Abstract] [Full Text] [Related]
119. Changes in chemosensitivity of skeletal muscles as related to endplate formation. Gordon T; Jones R; Vrbova G Prog Neurobiol; 1976; 3(2):103-36. PubMed ID: 778916 [No Abstract] [Full Text] [Related]